These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 4153206)

  • 21. Effects of intracerebroventricularly injected glucagon-like peptide-1 on cardiovascular parameters; role of central cholinergic system and vasopressin.
    Isbil-Buyukcoskun N; Gulec G
    Regul Pept; 2004 Apr; 118(1-2):33-8. PubMed ID: 14759554
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Myocardial effects of phentolamine.
    Das PK; Parratt JR
    Br J Pharmacol; 1970 Sep; 40(1):150P-151P. PubMed ID: 4395081
    [No Abstract]   [Full Text] [Related]  

  • 23. [Effect of blocking the beta-adrenergic receptors on ventricular diastole and on the systole of the left atrium in normal subjects. (Evaluation with the polygraphic method)].
    Vitale P; Mazza F; Jacono A
    Minerva Cardioangiol; 1971 Aug; 19(8):418-23. PubMed ID: 4397763
    [No Abstract]   [Full Text] [Related]  

  • 24. The influence of adrenergic blocking agents on the pressor response to vasopressin.
    Supek Z; Gjuris V; Geber J; Uroić B; Marijan-Janković N; Kunec-Vajić E
    Acta Med Iugosl; 1977; 31(3):217-24. PubMed ID: 18878
    [No Abstract]   [Full Text] [Related]  

  • 25. [Pharmacological basis of the use of adrenergic beta blockaders in arterial hypertension therapy].
    Durão V
    Acta Med Port; 1979; 1(1):117-31. PubMed ID: 44962
    [No Abstract]   [Full Text] [Related]  

  • 26. [Electrical properties of a new beta-blocker agent, tertatolol, in man].
    Touboul P; Atallah G; Kirkorian G; Lamaud M; Moleur P
    Therapie; 1983; 38(4):371-8. PubMed ID: 6139893
    [No Abstract]   [Full Text] [Related]  

  • 27. [Cardiovascular effects of glucagon].
    Lavarenne J
    Therapie; 1974; 29(2):161-84. PubMed ID: 4368071
    [No Abstract]   [Full Text] [Related]  

  • 28. [The effect of hypophyseal protein extracts on hemodynamics and the rhythm of cardiac activity].
    Abinder AA; Kiseleva AG
    Fiziol Zh SSSR Im I M Sechenova; 1975 Aug; 61(8):1253-7. PubMed ID: 1228003
    [No Abstract]   [Full Text] [Related]  

  • 29. Cardiovascular effects of tyramine: adrenergic and cholinergic interactions.
    Khwanchuea R; Mulvany MJ; Jansakul C
    Eur J Pharmacol; 2008 Jan; 579(1-3):308-17. PubMed ID: 18036584
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of the effects on renin release of beta adrenergic antagonists with differing properties.
    Weber MA; Stokes GS; Gain JM
    J Clin Invest; 1974 Dec; 54(6):1413-9. PubMed ID: 4154950
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interaction of cholecystokinin (CCK-33) and its C-terminal fragments: CCK-8 and CCK-4 with alpha- and beta-adrenoceptor agonists and antagonists in the cardiovascular system of rats. Part A.
    Wiśniewska RJ
    Pol J Pharmacol; 1998; 50(3):203-12. PubMed ID: 9861628
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Systemic and ocular effects of alpha 2-adrenergic stimulating and beta 2-blocking agents.
    Apponi-Battini G; Barra A; De Simone C; Rossi F; Berrino L; Cazzola M; Marmo E
    J Med; 1984; 15(2):126-34. PubMed ID: 6150961
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of o-2-hydroxy-3-(tert.-butylamino) propoxybenzonitrile HCl (KO 1366) on beta adrenergic receptors in the cardiovascular system.
    Nayler WG; Tay J
    J Pharmacol Exp Ther; 1972 Feb; 180(2):302-16. PubMed ID: 4400889
    [No Abstract]   [Full Text] [Related]  

  • 34. The action of propranolol on the dog heart.
    Harry JD; Linden RJ; Snow HM
    Br J Pharmacol; 1972 May; 45(1):155P-156P. PubMed ID: 4402822
    [No Abstract]   [Full Text] [Related]  

  • 35. In vitro and in vivo electrocardiographic evaluation of the novel calcium antagonist monatepil on cardiac conduction system.
    Nose I; Kataoka T; Honda Y; Yamada T; Ikeno A; Fukuya F; Minato H; Takeyama K; Hosoki K; Karasawa T
    Arzneimittelforschung; 1993 Jul; 43(7):722-8. PubMed ID: 8369002
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Compared effects of a beta adrenergic blockader and a ganglioplegic on auriculo-ventricular conduction in rabbits].
    Macri I; Macri PR; Duchêne-Marullaz P
    C R Seances Soc Biol Fil; 1970; 164(4):791-4. PubMed ID: 4396654
    [No Abstract]   [Full Text] [Related]  

  • 37. [Effect of adrenomimetic, adreno- and ganglionic-blocking agents during hyperbaric oxygenation].
    Filatov AF; Reznikov KM
    Farmakol Toksikol; 1982; 45(2):35-9. PubMed ID: 6122598
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peripheral mechanisms involved in the pressor and bradycardic effects of centrally administered arachidonic acid.
    Aydin C; Yalcin M
    Prostaglandins Leukot Essent Fatty Acids; 2008 Jun; 78(6):361-8. PubMed ID: 18571395
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effect of propafenon on the electric activity of the rabbit heart "in vitro"].
    de Carvalho AP; de Saldenã LS; Cukierman S
    Arq Bras Cardiol; 1979 Nov; 33(5):383-9. PubMed ID: 550773
    [No Abstract]   [Full Text] [Related]  

  • 40. Some cardiac metabolic and haemodynamic alterations due to adrenergic beta-receptor blockade.
    Szekeres L; Udvary E; Papp JG
    Acta Biol Med Ger; 1972; 28(6):1031-9. PubMed ID: 4404698
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.